Bastien Masson

Lead Scientist & Head of Product Development

Myria Biosciences

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Bastien Masson serves as the Lead Scientist and Head of Product Development at Oria Bioscience in France. His research focuses on pulmonary arterial hypertension and its pathophysiological mechanisms, as highlighted in his recent articles. His work examines calcium cycling, ion channels, and potential therapeutic targets within the cardiovascular system.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (3)

Carmen Bras Silva

Assistant Professor

Faculty of Medicine of the University of Porto

PORTUGAL

View details

Fabrice Antigny

INSERM

FRANCE

View details

sebastien bonnet

Institut universitaire de cardiologie et de pneumologie de Québec

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bastien Masson

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Ca 2+ Cycling Alteration in a Porcine Model of Right Ventricular Dysfunction

Lysosomal Ion Channels and Transporters: Recent Findings, Therapeutic Potential, and Technical Approaches

Unraveling the Impact of miR-146a in Pulmonary Arterial Hypertension Pathophysiology and Right Ventricular Function

Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction

Involvement of SUR2/Kir6.1 channel in the physiopathology of pulmonary arterial hypertension

Contribution of TRPC channels in human and experimental pulmonary arterial hypertension.

The SOCE Machinery: An Unbalanced Knowledge between Left and Right Ventricular Pathophysiology

SUR1 as a New Therapeutic Target for Pulmonary Arterial Hypertension

Orai1 Inhibitors as Potential Treatments for Pulmonary Arterial Hypertension

Role of Store-Operated Ca<sup>2+</sup> Entry in the Pulmonary Vascular Remodeling Occurring in Pulmonary Arterial Hypertension

Collaborators (3)

Carmen Bras Silva

Fabrice Antigny

sebastien bonnet

Make your next move.